Asensus Surgical, Inc. (ASXC) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2021
August 5, 2021 4:05 PM EDTRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery, today announced its operating and financial results for the second quarter 2021.
Recent Highlights
Signed two lease agreements with hospitals to install Senhance® Surgical Systems Over 1,000 global procedures performed using Senhance during the first half of 2021, the highest first half performance achieved Over 150 procedures have been performed utilizing the Intelligent... More